Sandbox:ap: Difference between revisions
Jump to navigation
Jump to search
Line 42: | Line 42: | ||
|- | |- | ||
! colspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Disorder}} | ! colspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Disorder}} | ||
!Mechanism of hypercalcemia | ! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Mechanism of hypercalcemia}} | ||
!Clinical features | ! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Clinical features}} | ||
!Laboratory findings | ! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Laboratory findings}} | ||
!Imaging & diagnostic modalities | ! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Imaging & diagnostic modalities}} | ||
|- | |- | ||
| rowspan="3" |Hyperparathyroidism | | rowspan="3" style="background: #F0FFFF; text-align: center;" |'''Hyperparathyroidism''' | ||
|Primary hyperparathyroidism | | style="background: #F0FFFF; text-align: center;" |Primary hyperparathyroidism | ||
|Increase in [[secretion]] of [[parathyroid hormone]] (PTH) from a primary process in [[parathyroid gland]]. Parathyroid hormone causes increase in serum calcium. | | style="background: #DCDCDC;" |Increase in [[secretion]] of [[parathyroid hormone]] (PTH) from a primary process in [[parathyroid gland]]. Parathyroid hormone causes increase in serum calcium. | ||
| | | style="background: #DCDCDC;" | | ||
* Usually asymptomatic | * Usually asymptomatic | ||
* Hypercalcemia detected on routine biochemical panel | * Hypercalcemia detected on routine biochemical panel | ||
| | | style="background: #DCDCDC;" | | ||
* ↑ PTH | * ↑ PTH | ||
* ↑ Calcium | * ↑ Calcium | ||
* ''↓/N Phosphate'' | * ''↓/N Phosphate'' | ||
* N/↑ calcitriol | * N/↑ calcitriol | ||
| rowspan="3" |Findings of bone resorption: | | rowspan="3" style="background: #DCDCDC;" |Findings of bone resorption: | ||
* X-ray | * X-ray | ||
* DXA | * DXA | ||
Line 76: | Line 76: | ||
* Intraoperative parathyroid hormone monitoring | * Intraoperative parathyroid hormone monitoring | ||
|- | |- | ||
|Secondary hyperparathyroidism | | style="background: #F0FFFF; text-align: center;" |Secondary hyperparathyroidism | ||
|Increase in [[secretion]] of [[parathyroid hormone]] (PTH) from a secondary process. Parathyroid hormone causes increase in serum calcium. | | style="background: #DCDCDC;" |Increase in [[secretion]] of [[parathyroid hormone]] (PTH) from a secondary process. Parathyroid hormone causes increase in serum calcium. | ||
| | | style="background: #DCDCDC;" | | ||
* May present with history of: | * May present with history of: | ||
** Chronic renal failure | ** Chronic renal failure | ||
** Vitamin D deficiency | ** Vitamin D deficiency | ||
| | | style="background: #DCDCDC;" | | ||
* '''↑''' PTH | * '''↑''' PTH | ||
* '''''↓/'''N'' Calcium | * '''''↓/'''N'' Calcium | ||
* ''↑ Phosphate'' | * ''↑ Phosphate'' | ||
|- | |- | ||
|Tertiary hyperparathyroidism | | style="background: #F0FFFF; text-align: center;" |Tertiary hyperparathyroidism | ||
|Continuous elevation of [[parathyroid hormone]] (PTH) even after successful treatment of the secondary cause of elevated parathyroid hormone. Parathyroid hormone causes increase in serum calcium. | | style="background: #DCDCDC;" |Continuous elevation of [[parathyroid hormone]] (PTH) even after successful treatment of the secondary cause of elevated parathyroid hormone. Parathyroid hormone causes increase in serum calcium. | ||
| | | style="background: #DCDCDC;" | | ||
* Usually present with history of: | * Usually present with history of: | ||
** Kidney transplant | ** Kidney transplant | ||
* Usually hyperplasia of all four parathyroid glands | * Usually hyperplasia of all four parathyroid glands | ||
| | | style="background: #DCDCDC;" | | ||
* '''↑''' PTH | * '''↑''' PTH | ||
* '''''↑''''' Calcium | * '''''↑''''' Calcium | ||
* ''↑ Phosphate'' | * ''↑ Phosphate'' | ||
|- | |- | ||
| rowspan="4" |Malignancy | | rowspan="4" style="background: #F0FFFF; text-align: center;" |'''Malignancy''' | ||
|Humoral hypercalcemia of malignancy | | style="background: #F0FFFF; text-align: center;" |Humoral hypercalcemia of malignancy | ||
|Tumor cells secretes parathyroid hormone related protein (PTHrP) which has similar action as parathyroid hormone. | | style="background: #DCDCDC;" |Tumor cells secretes parathyroid hormone related protein (PTHrP) which has similar action as parathyroid hormone. | ||
| | | style="background: #DCDCDC;" | | ||
* Most common cause of malignancy related hypercalcemia. | * Most common cause of malignancy related hypercalcemia. | ||
* Usually present in solid tumors | * Usually present in solid tumors | ||
| | | style="background: #DCDCDC;" | | ||
* '''↑''' PTHrP | * '''↑''' PTHrP | ||
* '''''↑''''' Calcium | * '''''↑''''' Calcium | ||
* '''↓'''/N P''hosphate'' | * '''↓'''/N P''hosphate'' | ||
* N/↑ Calcitriol | * N/↑ Calcitriol | ||
| | | style="background: #DCDCDC;" | | ||
* Chest X-ray | * Chest X-ray | ||
* CT scan | * CT scan | ||
* MRI | * MRI | ||
|- | |- | ||
|Osteolytic tumors | | style="background: #F0FFFF; text-align: center;" |Osteolytic tumors | ||
|Multiple myeloma produces osteolysis of bones causing hypercalcemia. Osteolytic metastasis can cause bone resorption causing hypercalcemia. | | style="background: #DCDCDC;" |Multiple myeloma produces osteolysis of bones causing hypercalcemia. Osteolytic metastasis can cause bone resorption causing hypercalcemia. | ||
| | | style="background: #DCDCDC;" | | ||
* Most commonly present in multiple myeloma and breast cancer. | * Most commonly present in multiple myeloma and breast cancer. | ||
| | | style="background: #DCDCDC;" | | ||
* '''''↓''''' PTH | * '''''↓''''' PTH | ||
* '''↑''' Calcium | * '''↑''' Calcium | ||
| | | style="background: #DCDCDC;" | | ||
* DXA | * DXA | ||
* X-ray | * X-ray | ||
Line 129: | Line 129: | ||
* Serum protein electrophoresis | * Serum protein electrophoresis | ||
|- | |- | ||
|Production of calcitirol | | style="background: #F0FFFF; text-align: center;" |Production of calcitirol | ||
|Some tumors has ectopic activity of 1-alpha-hydroxylase leading to increased production of calcitriol. Calcitriol is active form of vitamin D and causes hypercalcemia. | | style="background: #DCDCDC;" |Some tumors has ectopic activity of 1-alpha-hydroxylase leading to increased production of calcitriol. Calcitriol is active form of vitamin D and causes hypercalcemia. | ||
| | | style="background: #DCDCDC;" | | ||
* Most commonly present in lymphomas and in some ovarian germ cell tumors. | * Most commonly present in lymphomas and in some ovarian germ cell tumors. | ||
| | | style="background: #DCDCDC;" | | ||
* '''↑''' Calcium | * '''↑''' Calcium | ||
* ↑ Calcitriol | * ↑ Calcitriol | ||
| | | style="background: #DCDCDC;" | | ||
* CT scan | * CT scan | ||
* MRI | * MRI | ||
|- | |- | ||
|Ectopic parathyroid hormone | | style="background: #F0FFFF; text-align: center;" |Ectopic parathyroid hormone | ||
|Some tumors leads to ectopic production of parathyroid hormone. | | style="background: #DCDCDC;" |Some tumors leads to ectopic production of parathyroid hormone. | ||
| | | style="background: #DCDCDC;" | | ||
* In rare instances, small cell carcinoma of lung may produce hypercalcemia by this process. | * In rare instances, small cell carcinoma of lung may produce hypercalcemia by this process. | ||
| | | style="background: #DCDCDC;" | | ||
* ↑ PTH | * ↑ PTH | ||
* ↑ Calcium | * ↑ Calcium | ||
* ''↓/N Phosphate'' | * ''↓/N Phosphate'' | ||
* N/↑ Calcitriol | * N/↑ Calcitriol | ||
| | | style="background: #DCDCDC;" | | ||
* Chest X-ray | * Chest X-ray | ||
* CT scan | * CT scan | ||
* MRI | * MRI | ||
|- | |- | ||
| rowspan="2" |Medication induced | | rowspan="2" style="background: #F0FFFF; text-align: center;" |'''Medication induced''' | ||
|Lithium | | style="background: #F0FFFF; text-align: center;" |Lithium | ||
|Lithium lowers urinary calcium and causes hypercalcemia. Lithium has been reported to cause an increase in parathyroid hormones and enlargement if parathyroid gland after weeks to months of therapy. | | style="background: #DCDCDC;" |Lithium lowers urinary calcium and causes hypercalcemia. Lithium has been reported to cause an increase in parathyroid hormones and enlargement if parathyroid gland after weeks to months of therapy. | ||
| | | style="background: #DCDCDC;" | | ||
* History of mood disorder | * History of mood disorder | ||
| | | style="background: #DCDCDC;" | | ||
* ↑ PTH | * ↑ PTH | ||
* ↑ Calcium | * ↑ Calcium | ||
| | | style="background: #DCDCDC;" | | ||
* Lithium levels | * Lithium levels | ||
|- | |- | ||
|Thiazide diuretics | | style="background: #F0FFFF; text-align: center;" |Thiazide diuretics | ||
|Thiazide diuretics lowers urinary calcium excretion and causes hypercalcemia | | style="background: #DCDCDC;" |Thiazide diuretics lowers urinary calcium excretion and causes hypercalcemia | ||
| | | style="background: #DCDCDC;" | | ||
* History of cardiac disorder | * History of cardiac disorder | ||
* Rarely causes hypercalcemia | * Rarely causes hypercalcemia | ||
| | | style="background: #DCDCDC;" | | ||
* ↑ Calcium | * ↑ Calcium | ||
| -- | | style="background: #DCDCDC;" |-- | ||
|- | |- | ||
| rowspan="2" |Nutritional | | rowspan="2" style="background: #F0FFFF; text-align: center;" |'''Nutritional''' | ||
|Milk-alkali syndrome | | style="background: #F0FFFF; text-align: center;" |Milk-alkali syndrome | ||
|Hypercalcemia is be caused by high intake of calcium carbonate | | style="background: #DCDCDC;" |Hypercalcemia is be caused by high intake of calcium carbonate | ||
| | | style="background: #DCDCDC;" | | ||
* History of | * History of | ||
** High milk intake | ** High milk intake | ||
Line 185: | Line 184: | ||
*** Dyspepsia | *** Dyspepsia | ||
* May lead to metabolic alkalosis and renal insufficiency. | * May lead to metabolic alkalosis and renal insufficiency. | ||
| | | style="background: #DCDCDC;" | | ||
* ↑ Calcium | * ↑ Calcium | ||
| | | style="background: #DCDCDC;" | | ||
* Renal function test | * Renal function test | ||
|- | |- | ||
|Vitamin D toxicity | | style="background: #F0FFFF; text-align: center;" |Vitamin D toxicity | ||
|Excess vitamin D causes increased absorption of calcium from intestine causing hypercalcemia. | | style="background: #DCDCDC;" |Excess vitamin D causes increased absorption of calcium from intestine causing hypercalcemia. | ||
| | | style="background: #DCDCDC;" | | ||
* History of: | * History of: | ||
** Excess intake vitamin D | ** Excess intake vitamin D | ||
** Excess milk fortified with vitamin D | ** Excess milk fortified with vitamin D | ||
** Topical application of vitamin D analogue analogue calcipotriol | ** Topical application of vitamin D analogue analogue calcipotriol | ||
| | | style="background: #DCDCDC;" | | ||
* '''↑''' Calcium | * '''↑''' Calcium | ||
* ↑ Vitamin D (calcidiol and/or calcitriol) | * ↑ Vitamin D (calcidiol and/or calcitriol) | ||
| -- | | style="background: #DCDCDC;" | -- | ||
|- | |- | ||
|Granulomatous disease | | style="background: #F0FFFF; text-align: center;" |'''Granulomatous disease''' | ||
|Sarcoidosis | | style="background: #F0FFFF; text-align: center;" |Sarcoidosis | ||
|Hypercalcemia is causes by endogeous production of calcitriol by disease-activated macrophages. | | style="background: #DCDCDC;" |Hypercalcemia is causes by endogeous production of calcitriol by disease-activated macrophages. | ||
| | | style="background: #DCDCDC;" | | ||
* History of: | * History of: | ||
** Cough | ** Cough | ||
Line 213: | Line 212: | ||
** Fever | ** Fever | ||
** Weight loss | ** Weight loss | ||
| | | style="background: #DCDCDC;" | | ||
* '''↑''' Calcium | * '''↑''' Calcium | ||
* ↑ Calcitriol | * ↑ Calcitriol | ||
* ↑ ACE levels | * ↑ ACE levels | ||
| | | style="background: #DCDCDC;" | | ||
* Chest X-ray | * Chest X-ray | ||
* Biopsy | * Biopsy | ||
|} | |} |
Revision as of 14:09, 8 September 2017
There are three types of hyperparathyroidism and should be differentiated between each other. Hyperparathyroidism should be differeniated from other causes of hypercalcemia. Causes of hypercalcemia include:
- Parathyroid related
- Primary hyperparathyroidism
- Typical primary hyperparathyroidism
- Familial hypocalciuric hypercalcemia
- Secondary hyperparathyroidism
- Tertiary hyperparathyroidism
- Primary hyperparathyroidism
- Non-parathyroid related
- Malignancy
- Para-neoplastic syndrome: Parathyroid hormone related peptide
- Hypercalcemia due to bone destruction
- Medication induced
- Thiazide diuretics
- Lithium
- Nutritional
- Milk alkali syndrome
- Vitamin D toxicity
- Granulomatous disease
- Sarcoidosis
- Surgical
- Immobilization
- Malignancy
Hypercalcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related to Parathyroid gland | Unrelated to parathyroid gland | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary hyperparathyroidism | Secondary hyperparathyroidism | Tertiary hyperparathyroidism | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Typical primary hyperparathyroidism | Familial hypocalciuric hypercalcemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malignancy | Medication induced | Nutritional | Granulomatous disease | Surgical | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Para-neoplastic syndrome: Parathyroid hormone related peptide | Metaplasia: Hypercalcemia due to bone destruction | Thiazide diuretics | Lithium | Milk alkali syndrome | Vitamin D toxicity | Sarcoidosis | Immobilization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential diagnosis
Differential diagnosis of hyperparathyroidism on the basis of hypercalcemia | |||||
---|---|---|---|---|---|
Disorder | Mechanism of hypercalcemia | Clinical features | Laboratory findings | Imaging & diagnostic modalities | |
Hyperparathyroidism | Primary hyperparathyroidism | Increase in secretion of parathyroid hormone (PTH) from a primary process in parathyroid gland. Parathyroid hormone causes increase in serum calcium. |
|
|
Findings of bone resorption:
Preoperative localization of hyperfunctioning parathyroid gland:
Predicting post-operative success:
|
Secondary hyperparathyroidism | Increase in secretion of parathyroid hormone (PTH) from a secondary process. Parathyroid hormone causes increase in serum calcium. |
|
| ||
Tertiary hyperparathyroidism | Continuous elevation of parathyroid hormone (PTH) even after successful treatment of the secondary cause of elevated parathyroid hormone. Parathyroid hormone causes increase in serum calcium. |
|
| ||
Malignancy | Humoral hypercalcemia of malignancy | Tumor cells secretes parathyroid hormone related protein (PTHrP) which has similar action as parathyroid hormone. |
|
|
|
Osteolytic tumors | Multiple myeloma produces osteolysis of bones causing hypercalcemia. Osteolytic metastasis can cause bone resorption causing hypercalcemia. |
|
|
| |
Production of calcitirol | Some tumors has ectopic activity of 1-alpha-hydroxylase leading to increased production of calcitriol. Calcitriol is active form of vitamin D and causes hypercalcemia. |
|
|
| |
Ectopic parathyroid hormone | Some tumors leads to ectopic production of parathyroid hormone. |
|
|
| |
Medication induced | Lithium | Lithium lowers urinary calcium and causes hypercalcemia. Lithium has been reported to cause an increase in parathyroid hormones and enlargement if parathyroid gland after weeks to months of therapy. |
|
|
|
Thiazide diuretics | Thiazide diuretics lowers urinary calcium excretion and causes hypercalcemia |
|
|
-- | |
Nutritional | Milk-alkali syndrome | Hypercalcemia is be caused by high intake of calcium carbonate |
|
|
|
Vitamin D toxicity | Excess vitamin D causes increased absorption of calcium from intestine causing hypercalcemia. |
|
|
-- | |
Granulomatous disease | Sarcoidosis | Hypercalcemia is causes by endogeous production of calcitriol by disease-activated macrophages. |
|
|
|